Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions

NCT03525912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2019-03-28

No results posted yet for this study

Summary

Evaluation of neuropsychiatric and cardiovascular side effects of low dose ketamine analgesic infusion for postoperative pain

Conditions

  • Pain, Postoperative
  • Ketamine Adverse Reaction

Interventions

DRUG

Ketamine

continuous infusion of low dose ketamine for postoperative pain

Sponsors & Collaborators

  • Universidad de Antioquia

    lead OTHER

Principal Investigators

  • Adriana M Cadavid, MD · Anesthesiology professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-03-31
Completion
2018-11-14

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03525912 on ClinicalTrials.gov